Advisory Research’s Zegna ZGN Stock Holding History

Advisory Research’s Portfolio ZGN Stock Details ZGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-81,273	Closed	-$1.13M	–	484
2023 Q3	$1.13M	Buy	81,273 +23,227	+40%	+$339K	0.16%	179
2023 Q2	$736K	Buy	+58,046	New	+$723K	0.09%	241
2022 Q2	–	Sell	-11,032	Closed	-$116K	–	440
2022 Q1	$116K	Buy	+11,032	New	+$111K	0.01%	352

Other funds holding ZGN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

PIF

Public Investment Fund Al Aqiq District, Riyadh, Saudi Arabia $12B AUM 0.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

TAM

Tabor Asset Management New York $249M AUM 48.59% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

NRCM

Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return

Advisory Research's ZGN Position: Q4 2023 in Review

Advisory Research sold out of Zegna (ZGN) in Q4 2023, closing a stake of 81,273 shares — an estimated $1.13M sold.

Advisory Research first reported a position in ZGN in Q1 2022 and held it in 3 quarters. The position peaked at $1.13M in Q3 2023. 59 funds tracked by Wall St. Rank hold ZGN as of Q4 2023.

Advisory Research reported no remaining Zegna position as of Q4 2023 after selling out during the quarter.
Advisory Research sold 81,273 Zegna shares in Q4 2023, an estimated $1.13M.
Advisory Research first reported a position in Zegna in Q1 2022 and held it in 3 quarters.
Advisory Research's Zegna position peaked at $1.13M in Q3 2023.
59 funds tracked by Wall St. Rank held Zegna as of Q4 2023.

Based on Advisory Research's 13F filing for Q4 2023, filed 13 Feb 2024.